Parkinson’s Foundation Adds James Monhart to its Board of Directors

NEW YORK & MIAMI (October 29, 2018) — The Parkinson’s Foundation today announced the election of James F.T. Monhart to its board of directors. 

"Jim brings an extraordinary passion for Parkinson's disease, along with tremendous skills and personal networks to help advance the mission," stated Howard Morgan, chairman of the Parkinson’s Foundation board. "His professional expertise and philanthropic commitment is a valuable addition to the board of directors." 

James F.T. Monhart

James F.T. Monhart is the Senior Vice President at The Northern Trust Company, a global financial services organization headquartered in Chicago. As Senior Credit Officer, he works on ways to expand Northern’s relationships with the wealth management segment. Mr. Monhart previously served on the National Parkinson Foundation board and has been involved in board-related activities with Youth Guidance, DePaul University, and the Lincoln Park Zoo. He resides in Chicago and holds an MBA in Finance from Washington University.

“I am honored to further my commitment to the Parkinson’s community and the Foundation by serving on its board of directors,” said Jim Monhart. “As someone living with Parkinson’s disease, the mission of the Parkinson’s Foundation is personal to me. I look forward to helping the Foundation achieve an even greater impact for all those living with and affected by this disease.”

A complete list of the Parkinson’s Foundation’s Board of Directors is available at


About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $400 million in Parkinson’s research and clinical care. Connect with us on Parkinson.orgFacebookTwitterInstagram or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the U.S. alone.

Back to Top